Bradley Lang Email

VP Research . Convelo Therapeutics

Current Roles

Employees:
22
Revenue:
$3.4M
About
Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.
Convelo Therapeutics Address
11000 Cedar Ave
Cleveland, OH

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.